Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | THPO | P40225 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.54 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.47 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 5/20 | 0.43 |
| ▸ | FNTB | P49356 | 5/20 | 0.43 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5579254 | 1.00 | ACE (0.60) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL296933 | 1.00 | ACE (0.60) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL29663240 | 1.00 | ACE (0.60) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL5665364 | 0.96 | ACE (0.56) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL16770240 | 0.96 | ACE (0.56) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL22969994 | 0.96 | ACE (0.56) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL7072854 | 0.96 | ACE (0.56) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL6809797 | 0.96 | ACE (0.56) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL29461530 | 0.91 | ACE (0.51) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL30011698 | 0.91 | ACE (0.51) | ACEKDM4EMAPTTHRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230410977-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES | 2023-12-21 | — | — | US | claimed |
| WO-2022140565-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES (US) | 2022-06-30 | — | — | WO | claimed |
| US-12161779-B2 | Three-dimensional implantable matrix with reduced foreign body response | TENSIVE SRL (IT) | 2024-12-10 | — | — | US | disclosed |
| CN-116322813-B | Three-dimensional implantable matrix for reducing foreign body response | 张力有限责任公司 | 2024-06-28 | — | — | CN | disclosed |
| EP-4204029-B1 | THREE-DIMENSIONAL IMPLANTABLE MATRIX WITH REDUCED FOREIGN BODY RESPONSE | TENSIVE S R L (IT) | 2024-04-24 | — | — | EP | disclosed |
| US-20230410977-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES | 2023-12-21 | — | — | US | disclosed |
| US-20230270918-A1 | THREE-DIMENSIONAL IMPLANTABLE MATRIX WITH REDUCED FOREIGN BODY RESPONSE | TENSIVE SRL (IT) | 2023-08-31 | — | — | US | disclosed |
| EP-4204029-A1 | THREE-DIMENSIONAL IMPLANTABLE MATRIX WITH REDUCED FOREIGN BODY RESPONSE | Tensive S.r.l. (IT) | 2023-07-05 | — | — | EP | disclosed |
| CN-116322813-A | Three-dimensional implantable matrix for reducing foreign body response | 张力有限责任公司 | 2023-06-23 | — | — | CN | disclosed |
| US-11596693-B2 | Antibody-drug conjugates and uses thereof | MABPLEX INTERNATIONAL CO., LTD (CN) | 2023-03-07 | — | — | US | disclosed |
| WO-2022140565-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES (US) | 2022-06-30 | — | — | WO | disclosed |
| EP-1601735-A1 | METHOD OF POLISHING A SILICON-CONTAINING DIELECTRIC | Cabot Microelectronics Corporation (US) | 2005-12-07 | — | — | EP | disclosed |
| EP-1432734-A4 | CYTOKINE RECEPTOR | COMMW SCIENT IND RES ORG (AU) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004069947-A1 | METHOD OF POLISHING A SILICON-CONTAINING DIELECTRIC | CABOT MICROELECTRONICS CORPORATION (US) | 2004-08-19 | — | — | WO | disclosed |
| US-20040152309-A1 | Method of polishing a silicon-containing dielectric | CABOT MICROELECTRONICS CORPORATION | 2004-08-05 | — | — | US | disclosed |
| EP-1432734-A1 | CYTOKINE RECEPTOR | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2004-06-30 | — | — | EP | disclosed |
| US-20030211116-A1 | Mhc peptides over-expressed on prostate cancer cells and methods of use | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2003-11-13 | — | — | US | disclosed |
| EP-1303287-A1 | MHC PEPTIDES OVER-EXPRESSED ON PROSTATE CANCER CELLS AND METHODS OF USE | Argonex Pharmaceuticals (US) | 2003-04-23 | — | — | EP | disclosed |
| WO-2003025017-A1 | CYTOKINE RECEPTOR | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-03-27 | — | — | WO | disclosed |
| WO-2001097827-A1 | MHC PEPTIDES OVER-EXPRESSED ON PROSTATE CANCER CELLS AND METHODS OF USE | ARGONEX PHARMACEUTICALS (US) | 2001-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11596693-B2 | Antibody-drug conjugates and uses thereof | DARS1, CD2, FCGR2A | ACE 4181/4885KDM4E 3240/4885MAPT 2441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.